Ischemic stroke is a devastating illness of enormous proportions in the United States, where it is the leading cause of disability.9–11 Although several treatment options are on the horizon, the U.S. Food and Drug Administration has currently approved only one medication (intravenous t-PA) for acute treatment of ischemic stroke. The gene discussed is PLAT; the disease is ischemic stroke.